Ignite Creation Date:
2024-05-06 @ 7:57 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06196632
Status:
RECRUITING
Last Update Posted:
2024-02-07
First Post:
2023-12-25
Brief Title:
Development and Validation of Models to Predict Functional Cure in Patients With CHB After Peg-IFN Based Therapy
Sponsor:
Qilu Hospital of Shandong University
Organization:
Qilu Hospital of Shandong University
Study Overview
Official Title:
Development and Validation of Logistic Regression Models to Predict Durable Functional Cure in Patients With Chronic Hepatitis B After Pegylated Interferon Alpha-2b Based Therapy
Status:
RECRUITING
Status Verified Date:
2023-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Hepatitis B virus HBV infection is prevalent across the world Functional cure is the optimal endpoint of antiviral therapy for chronic hepatitis B virus HBV infection Currently available anti-HBV therapy includes nucleoside analogs NAs and peginterferon-α Peg-IFNα Combination of Peg-IFNα and NAs each with different mechanisms of action is an attractive approach for treating chronic HBV infection In this study we aim to establish logistic regression models to predict durable functional cure in patients with CHB treated by combination of Peg-IFNα and NAs which might be useful for clinical physicians to make personalized treatment decisions These models will be constructed using baseline routine clinical laboratory indicators with high diagnostic accuracy These models might be widely applicable to almost all medical institutions and will effectively promote the application of Peg IFN α plus NAs therapy in clinical work The findings in this study might greatly improve the functional cure rate of CHB and reducing the incidence rate and mortality of HBV related end-stage liver diseases
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None